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Ca2+ Transients in Cardiac Myocytes Measured with High and Low
Affinity Ca2+ Indicators
Joshua R. Berlin and Masato Konishi*
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ABSTRACT Intracellular calcium ion ([Ca2+],) transients were measured in voltage-clamped rat cardiac myocytes with fura-2
or furaptra to quantitate rapid changes in [Ca2+]j. Patch electrode solutions contained the K+ salt of fura-2 (50 PM) or furaptra
(300 PM). With identical experimental conditions, peak amplitude of stimulated [Ca2+], transients in furaptra-loaded myocytes
was 4- to 6-fold greater than that in fura-2-loaded cells. To determine the reason for this discrepancy, intracellular fura-2 Ca2+
buffering, kinetics of Ca2+ binding, and optical properties were examined. Decreasing cellular fura-2 concentration by lowering
electrode fura-2 concentration 5-fold, decreased the difference between the amplitudes of [Ca2+], transients in fura-2 and
furaptra-loaded myocytes by twofold. Thus, fura-2 buffers [Ca2+], under these conditions; however, Ca2+ buffering is not the
only factor that explains the different amplitudes of the [Ca2+], transients measured with these indicators. From the temporal
comparison of the [Ca2+], transients measured with fura-2 and furaptra, the apparent reverse rate constant for Ca2+ binding
of fura-2 was at least 65s-1, much faster than previously reported in skeletal muscle fibers. These binding kinetics do not explain
the differences in the size of the [Ca2+], transients reported by fura-2 and furaptra. Parameters for fura-2 calibration, Rmin, Rmax,
and f, were obtained in salt solutions (in vitro) and in myocytes exposed to the Ca2+ ionophore, 4-BrA23187, in EGTA-buffered
solutions (in situ). Calibration of fura-2 fluorescence signals with these in situ parameters yielded [Ca2+]i transients whose peak
amplitude was 50-100% larger than those calculated with in vitro parameters. Thus, in vitro calibration of fura-2 fluorescence
significantly underestimates the amplitude of the [Ca2+]i transient. These data suggest that the difference in amplitude of [Ca2+i
transients in fura-2 and furaptra-loaded myocytes is due, in part, to Ca2+ buffering by fura-2 and use of in vitro calibration
parameters.
INTRODUCTION
Furaptra, the fluorescent indicator sensitive to Mg2+ and
Ca2+, has been shown to be useful for measuring stimulated
[Ca2+], transients in rat cardiac myocytes (Cleeman and Mo-
rad, 1991; Konishi and Berlin, 1993). A surprising result,
however, was that the size of the [Ca21], transients averaged
1.5 ,uM and were as large as 3-4 ,uM in some cells (Konishi
and Berlin, 1993). Fluorescent Ca21 indicators more com-
monly used in single myocytes, such as indo-1 and fura-2,
report [Ca2+], transients which, on average, are only several
hundred nanomolar in amplitude (Bers et al., 1990; Cleeman
and Morad, 1991). The finding that these indicators report
[Ca21], transients of different amplitude may point out our
limited ability to quantitate transient changes in [Ca2+]i and,
in general, to measure [Ca2+], in cardiac myocytes.
Measurements of [Ca2+], in skeletal muscle have also
been performed with a wide variety of Ca2+ indicators (re-
viewed by Blinks et al., 1982), and similar to the results
above, the apparent amplitude of the [Ca21]1 transient in
response to a stimulus varies quite widely with the Ca21
indicator used (Maylie et al., 1987a, b). Much of this vari-
ability has been attributed to differences in the Ca2+ affinity
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(and consequently, the kinetics of Ca2" binding) and the
degree of indicator binding to intracellular constituents (Hi-
rota et al., 1989). These two factors may also affect Ca2"
measurements in heart muscle, and they suggest that using
a variety of Ca2" indicators could be important for deter-
minations of [Ca2"]i in cardiac myocytes.
Fura-2 has a high affinity for Ca21 with an in vitro KD
close to 200 nM (Grynkiewicz et al., 1985). Given that
[Ca21], can exceed this level during the stimulated [Ca21],
transient (Allen and Kurihara, 1978; Cannell et al., 1987;
Bers et al., 1990; Cleeman and Morad, 1991), a high degree
of Ca2' binding to the indicator is expected. Furthermore,
high affinity for Ca2' results in ion binding kinetics that limit
the ability of these indicators to accurately follow rapid
changes in [Ca21]1. In fact, the Ca2+ binding kinetics of
fura-2 have been calculated to be much slower in the cellular
environment (Baylor and Hollingworth, 1988; Klein et al.,
1988) than in salt solutions (Jackson et al., 1987; Kao and
Tsien, 1988), so that this problem may be particularly im-
portant. Limited binding kinetics and saturation of fura-2
have been shown to lead to underestimates of peak [Ca2+],
during twitches in skeletal muscle fibers; however, the pos-
sibility of similar limitations for fura-2 have not been well
studied in cardiac muscle.
An additional concern with the use of high affinity indi-
cators such as fura-2 is that they may significantly contribute
to the Ca2' buffering capacity within the cardiac myoplasm
(Backx and ter Keurs, 1993). This problem is potentially
much greater in cardiac myocytes than skeletal muscle fibers
because the smaller capacity of the intrinsic Ca2' buffers and
the need to achieve usable signal-to-noise ratios in spite of
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the small size (i.e., short pathlength) of heart cells. Similar
considerations would also apply to the use of other high
affinity Ca21 indicators, such as indo-1, in cardiac myocytes.
The utility of furaptra as a Ca21 indicator derives from
several factors. The structure of furaptra is quite similar to
fura-2, with the same chromophore but lacking the nitro-
benzyl ring adjacent to the chelation sites (Raju et al., 1989).
As a result, the optical properties of furaptra are quite similar
to fura-2, so that the same equipment can be used for both
indicators. The Ca2+ affinity of furaptra (approximately 50
,uM; Raju et al., 1989), however, is 250 times lower than
fura-2. This lower Ca2+ affinity suggests that factors such as
saturation, buffering, and kinetics of Ca2+ binding are less
likely to be major limitations in the ability of furaptra to
report rapid and large changes in [Ca21],.
Thus, in this study, we have compared [Ca21], transients
measured in rat cardiac myocytes with fura-2 and furaptra to
investigate whether Ca2+ buffering and Ca2+ binding ki-
netics are factors in the measurement of transient changes of
[Ca21], in cardiac myocytes. Some of these results have been
published previously in abstract form (Konishi and Berlin,
1991; Berlin and Konishi, 1992).
EXPERIMENTAL PROCEDURES
General
The experimental techniques used in this study and the experimental set-up
have been described previously (Berlin et al., 1989; Konishi and Berlin,
1993). In brief, enzymatically dispersed single ventricular myocytes of the
rat heart were placed in a superfusion bath (Cannell and Lederer, 1986) on
the stage of an inverted microscope and superfused with a solution con-
taining (in mM) 140 NaCl, 4 KCI, 1 MgCl2, 2 CaCl2, 10 Glucose, 10 HEPES
(N-(2-hydroxyethyl)piperizine-N'-(2-ethanesulfonic acid)), pH 7.4. Cells
were voltage-clamped with a single patch electrode (Hamill et al., 1981)
which contained an intracellular salt solution (in millimolar): 70 cesium
glutamate, 50 KCl, 15 CsCl, 1 MgCl2, 2.5 ATP, K+ salt, 0.01 EGTA, and
25 PIPES (1,4-piperazinediethanesulfonic acid, pH 7.2) that included either
fura-2 at the indicated concentration or furaptra (300 ,uM) as a K+ salt. In
experiments shown in Fig. 5 B, 10 mM NaCl was added to the electrode
solution without adjusting for changes in ionic strength. Zero current and
background fluorescence were measured after gigOhm seal formation. The
membrane patch under the electrode was then ruptured to establish a whole
cell voltage clamp and allow diffusion of the indicator into the cell. Except
where indicated, measurements were carried out when indicator loading was
near equilibrium. Fluorescence at 500 nm was measured as described in
Konishi and Berlin (1993) with illumination wavelengths of 340 and 380
nm for fura-2, and 350 and 370 nm for furaptra.
All data were recorded on videotape (Instrutech, VR-100, Elmont, NY)
and digitized off-line at 1 KHz (A2D+; Medical Systems, Greenvale,
NY) with an eight-pole Bessel low-pass filter at 500 Hz (-3 dB). Furaptra
transients reported here are the average of six to eight fluorescence transients
measured at each illumination wavelength. Fura-2 transients are determined
from two transients recorded with consecutive depolarizations, one at each
illumination wavelength.
Experiments were performed at room temperature (23-24°C).
termined using HEDTA (N-hydroxyethylenediaminetriacetic acid)-buffered
solutions (Konishi and Berlin, 1993). The calculated KD(Ca) for furaptra
was 47 ,LM and KD(Mg) was 3.6 mM. For fura-2, calibration solutions
contained (in millimolar) 140 KCl, 1 MgCl2, 1 ,uM fura-2 (K+ salt), 5
EGTA, and 10 PIPES, pH 7.2. Various amounts of CaCl2 were added to
achieve the desired free [Ca2+] according to the computer program, Max-
Chelator (written by Chris Patton, Hopkins Marine Station) which uses
equations from Fabiato and Fabiato (1979) with dissociation constants de-
termined by Harrison and Bers (1987) and Martell and Smith (1974). Fig.
1 shows the relationship between the ratio of fura-2 fluorescence intensity
versus [Ca2+]. The KD was calculated to be 239 nM by fitting the raw
fluorescence intensity versus log [Ca2+] data with a sigmoid curve which
assumed one-to-one binding stoichiometry (not shown).
Calibration of furaptra signals
Calibration of furaptra fluorescence signals was carried out as described
previously (Konishi and Berlin, 1993). Briefly, fluorescence intensity at
500 nm was measured during illumination with 350 and 370 nm light.
Fluorescence measured during illumination with 350-nm light was taken to
be the isosbestic point. Fluorescence during 370-nm illumination was then
multiplied by the change in the fluorescence intensity during 350-nm il-
lumination to correct for movement artifacts (Flcorr(t)). The change in the
Ca2+-sensitive portion of Flcorr(t) was then converted to a fractional change
in the free indicator (AfD(t)) by the following:
AfD(t) Fl,.,(Wst)-Fl Fli = FlEf,(rest) X b (1)
where Flc,,0(rest) is the fluorescence intensity during 370-nm illumination
just prior to the voltage clamp depolarization, Fli is the Ca2l-insensitive
component of the fluorescence signal during 370-nm illumination, and Ef
and Eb are the fluorescence coefficients for Ca2l-free and -bound forms of
the indicator, respectively. The value of Eb/Ef was 0.1 from in vitro cali-
brations as described by Konishi and Berlin (1993). To determine if this
value might be significantly altered by indicator binding to proteins in the
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In vitro calibration
In order to estimate parameter values for fluorescence calibration, in vitro
measurements of fura-2 and furaptra fluorescence were carried out on the
experimental equipment using glass capillaries approximately 100 ,um in
diameter. For furaptra, Ca2+-dependent changes in fluorescence were de-
FIGURE 1 In vitro calibration of fura-2. Calibration of fura-2 in a
100-,um diameter glass capillary. The solid line was determined by fitting
the data with a nonlinear least squares routine to a sigmoid equation with
the following parameters: Rmin = 0.43, Rmax = 13.4, and KD04 = 3.2 ,uM,
Hill coefficient = 1.
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cell, calibrations were also carried out in the presence of 20 mg/ml Aldolase,
a protein concentration that appears to bind most of the furaptra. Under these
conditions, EJEf averaged 0.12 in two trials. The value of b/ff determined
in the absence of Aldolase was used to convert furaptra fluorescence
to [Ca2+]i.
The apparentKD for Ca2+ is much higher than the [Ca2+], concentrations
encountered in these studies. Thus, AfD(t) converts directly to A[Ca2+]i, as
in the following:
2 ]i = KD X [1 - AfD(t)] = KD X AfD(t) (2)
where AfDCa(t) is the change in the fraction of Ca2+-bound indicator and
KD is calculated to be 54,M in Konishi and Berlin (1993) and in the present
study. This calibration procedure assumes that [Mg2+], is 0.5 mM and that
it does not change significantly during the [Ca2+], transient. These assump-
tions were addressed in Konishi and Berlin (1993).
Calibration of fura-2 signals
Fura-2 fluorescence signals from cells were calibrated in terms of [Ca2+],
with the ratiometric calibration procedure used by Grynkiewicz et al. (1985).
[Ca2+] = KD X X(R R) (3)
where R,,,in, Rm., and 03 have their usual meaning. For the most calibrations,
values of 0.45, 14.6, and 13.1 obtained in vitro (see above) were used for
Rmin, Rm.x, and 13, respectively (in vitro calibration).
In some cells, in situ estimation of these parameter values for fura-2
fluorescence was performed by a modification of the method of Li et al.
(1987). At the end of an experiment, the myocyte was superfused for 15 min
with an EGTA-buffered, Ca-ionophore solution containing (in millimolar)
140 NaCl, 4 KCl, 2 MgCl2, 10 glucose, 2.5 K2EGTA, 0.025 4-Br A23187,
0.01 nigericin, 0.010 "1799" (bis-(hexafluoracetonyl)acetone) and 10
HEPES, pH 7.4 (Rmin solution). Cell fluorescence was monitored periodi-
cally until fluorescence ratio reached a new steady-state. The superfusion
solution was then changed to a high Ca2+ solution containing (in millimolar)
145 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, 10 HEPES, pH 7.4 (R.ax solution).
After several minutes, during which time the fluorescence ratio reached
a maximum, the superfusion solution was changed to a Mn2+ solution
containing (in millimolar) 140 NaCl, 4KCl, 1 MgCl2, 1 MnCl2, 10 glucose,
10 HEPES, pH 7.4 (Rback solution) to determine the level of background
fluorescence.
The R,i,,n solution contained the compound 1799, a nonfluorescent mi-
tochondrial uncoupler. Control experiments demonstrated that background
fluorescence (reflecting the cellular NAD/NADH balance) changed on ex-
posure to 1799, but remained unchanged thereafter. Thus, to calculate fura-
2-dependent fluorescence, fluorescence values obtained in Rback were sub-
tracted from those values obtained in Rmin solution and Rma. solution. For
calculation of fura-2 fluorescence levels prior to exposure to 1799, back-
ground fluorescence determined after seal formation (at the beginning of the
experiment) was subtracted from total cell fluorescence (Berlin et al., 1989).
Estimation of intracellular fura-2 concentration
In some experiments, cytosolic fura-2 concentration in myocytes was es-
timated by comparing fluorescence levels in cells and in glass capillaries
filled with a fura-2 containing solution (see below).
Myocytes were voltage-clamped with electrodes containing an intracel-
lular salt solution with 50,uM fura-2. After establishing a whole-cell voltage
clamp, fluorescence levels were allowed to come to a steady state (ap-
proximately 15 min). Fluorescence intensity was measured during illumi-
nation with 360-nm light, and the illumination area was limited to approxi-
mately 50-75 gm by a field stop in the illumination path. The cell was
positioned so that both ends of the cell were beyond the edge of the illu-
mination field. The isosbestic point for the indicator was chosen for these
experiments so that fluorescence levels would be Ca2+-independent.
Konishi et al. (1988) found that fluorescence intensity of fura-2 is affected
by protein binding; however, no corrections for changes in indicator fluo-
rescence properties were performed.
In these experiments, cells with simple geometry were chosen to facilitate
determination of cell dimensions. Cell width was measured using a reticle
in the eyepiece. Cell depth was measured by determining the distance be-
tween the first in-focus plane at the top and bottom surfaces of the cell
viewed with a CCD camera. Focusing depth was calibrated using latex beads
with diameters of 5-25 gm. Intracellular volume accessible to fura-2 was
calculated assuming the cell was a rectangular parallelepiped with 25% of
cell volume occupied by membrane-bound structures (e.g., mitochondria)
which excluded the indicator. After determination of the intracellular vol-
ume accessible to fura-2, fluorescence intensity was normalized to acces-
sible volume.
Immediately following the determination of cell fluorescence, glass cap-
illaries with diameters between 10 and 20 ,um (similar to cell depth) were
placed under the microscope without changing the illumination field stop.
The capillaries were filled with the same intracellular solution used in the
voltage-clamping electrodes. Fluorescence levels were measured during
360-nm illumination, and background fluorescence was measured in cap-
illaries filled with indicator-free solutions. Inside diameters were measured
using the eyepiece reticle so that the volume of illuminated solution could
be calculated. Fluorescence was also normalized to illuminated volume.
Cytosolic fura-2 concentration was then calculated as the ratio of nor-
malized fluorescence intensities of the cell and the capillary multiplied by
50 ,uM.
Materials
All chemicals were reagent grade. furaptra (Magfura-2, tetrapotassium
salt, lot 9A), fura-2 (pentapotassium salt), BAPTA (tetrapotassium salt),
4-Br A23187, and nigericin were purchased from Molecular Probes Inc.
(Eugene, OR). Compound 1799 was a generous gift of Du Pont Inc.
(Wilmington, DE).
Statistics
Statistical values are expressed as mean ± SE. Statistical significance was
tested by two-tailed t tests (p < 0.05).
RESULTS
Fig. 2 shows a typical [Ca21]1 transient elicited with depo-
larizations of 50-ms duration from -70 to + 10 mV delivered
at 0.2 Hz. The myocyte was voltage-clamped with an elec-
trode containing 50 ,uM fura-2. The middle panel shows the
ratio of fluorescence intensities calculated after subtraction
of background fluorescence at the two illumination wave-
lengths (340 and 380 nm). The change in fluorescence ratio
was then converted to [Ca2+] using a calibration curve simi-
lar to that in Fig. 1 with the assumption that Ca2+ was in rapid
equilibrium with fura-2. Using this in vitro calibration
method, resting [Ca21], in the myocyte was estimated to be
39 nM and the peak of the [Ca21], transient, estimated to be
422 nM, was reached 32 ms after the beginning of the de-
polarization. [Ca2+]i declined thereafter but, even after 500
ms, remained slightly elevated. The time course of this tran-
sient is typical for those experiments carried out at room
temperature. Table 1 shows that the average amplitude of the
[Ca2+], transient was 395 ± 63 nM and the time to peak
[Ca2+], was estimated at 39 ± 2 ms.
These experiments were performed under identical experi-
mental conditions as experiments in which the Ca21 indi-
cator was furaptra (Konishi and Berlin, 1993). The results of
experiments using furaptra are also summarized in Table 1.
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FIGURE 2 [Ca21], transient measured with fura-2. The voltage (top),
ratio of 500-nm fluorescence intensities (middle), and [Ca21], transient (bot-
tom) are shown for a myocyte voltage clamped with an electrode containing
50 ,uM fura-2. The calibration parameters for conversion of ratio to [Ca2+]
are Rmin = 0.41, Rmax = 13.0, j3 = 13.1, and KD = 239 nM.
TABLE 1 Calcium transients measured with fura-2 and
furaptra
fura-2 furaptra
Mean ± SE
[Ca2+] (nM)
Rest 48 ± 7
Peak 440 ± 48 1523 ± 252
ISO effect (% increase) 41 ± 12 84 ± 24
Time-to-peak (ms) 39 ± 1 36 + 3
Calculated peak [Ca2+]lot (,IM) 58 + 8 77 ± 9
Summary data of [Ca21], transients measured in cells (n = 5-7) voltage-
clamped with electrodes containing 50 ,iM fura-2 or 300 ,uM furaptra. Data
for furaptra loaded cells from Konishi and Berlin (1993).
As previously described (Konishi and Berlin, 1993), furaptra
signals allow changes in [Ca2+]i, but not resting [Ca21]i, to
be determined. Thus, the obvious difference between [Ca21],
transients reported with fura-2 and furaptra, is that the
average amplitude of the [Ca21], transients measured with
furaptra are almost four times larger than those measured
with fura-2. In spite of the difference in amplitude, the av-
erage time-to-peak [Ca21], was similar. These results suggest
that a major discrepancy exists between [Ca21], transients
determined in myocytes loaded with fura-2 and those cells
loaded with furaptra. In order to resolve the apparent dis-
crepancy in the size of the [Ca21]i transients reported by
these two indicators, several possibilities were explored.
A potential problem with the comparison made in Table 1
was that the accumulated data were obtained from experi-
ments performed on different experimental days. Since sig-
nificant day-to-day variability is observed with acutely dis-
sociated myocytes, it is difficult to rule out the possibility that
the difference in peak amplitude (and the similarity in time
to peak) is fortuitous. In order to overcome this day-to-day
variability, a series of experiments were performed on the
same day in which cells were divided into two groups where
the Ca2" indicator was fura-2 or furaptra. It was necessary
to perform experiments in different cells, because the optical
properties of fura-2 and furaptra are almost identical. The
amplitude of [Ca21], transients calibrated from furaptra and
fura-2 fluorescence signals were 1.98 + 0.23 ,uM (n = 4) and
0.31 ± 0.10 ,uM (n = 3), respectively. The time to peak
[Ca21], was, on the other hand, 29 ± 3 ms (n = 4) and 42
± 8 ms (n = 3) for furaptra and fura-2 transients, respectively
(see Fig. 5 B and below). Thus, the results from the same day
also demonstrate that [Ca21], transients from fura-2-loaded
cells are significantly smaller (p < 0.05 by t test) in peak
amplitude (by a factor of 6.4).
One explanation for this result was that fura-2 underes-
timated the true [Ca2+]i during the transient, because it be-
came highly saturated. To test this possibility we examined
the effect of 10 ,uM isoproterenol on the size of the [Ca21],
transient in fura-2-loaded cells. As expected, exposure to
isoproterenol increased the peak amplitude of the [Ca21],
transient (41%, on average). The magnitude of this effect was
smaller but not significantly different than the increase in the
[Ca21], transient observed in furaptra-loaded myocytes
(Table 1). Thus, although fura-2 becomes more highly bound
with Ca21 than furaptra, the level of fura-2 binding remains
below saturation.
Other possible explanations for the discrepancy in the am-
plitude of [Ca21], transients reported by fura-2 and furaptra
could include 1) Ca2' buffering by fura-2, 2) slow Ca2+
binding kinetics of fura-2, and 3) errors in calibration of the
fluorescence signals. All three of these potential factors are
examined below.
Fura-2 buffering of [Ca2+J
Differences in the size of the [Ca21], transient measured with
furaptra and fura-2 may reflect significant buffering of the
[Ca2+], transient by fura-2. This explanation is plausible,
because the Ca2+ affinity of fura-2 (KD = 239 nM under
in vitro conditions) is near physiological [Ca2+j, so that it
could greatly increase the Ca2' buffering capacity of the cell.
This possibility was tested by measuring the stimulated fluo-
rescence transient at various times during indicator loading
from a voltage clamp electrode containing 50 p.M fura-2
(Fig. 3). The top panels show the fura-2 fluorescence level
increased threefold during measurements made 120, 320, and
570 s after establishing a whole-cell voltage clamp. How-
ever, during indicator loading, it is clear that the size of the
[Ca2+1] transient, estimated as fluorescence ratio, is de-
creased several-fold. These data are shown as fluorescence
ratio rather than [Ca2+], to demonstrate that simple calibra-
tion errors arising from changes in signal-to-noise ratio, as
Berlin and Konishi 1635
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FIGURE 3 Effect of fura-2 loading on
the amplitude of the [Ca21], transient.
The top panels show the level of fluo-
rescence measured at the isosbestic
point, with 360-nm illumination. The
time after establishing a whole cell volt-
age clamp is indicated. The bottom pan-
els show the [Ca21], transient, displayed
as the ratio of fluorescence intensity,
elicited by 50 ms depolarizations from
-70 to +10 mV.
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the indicator loads, do not explain the decrease in the size of
the [Ca2+]i transient.
This result is at odds with the effect of indicator loading
reported by Cleeman and Morad (1991) where an 8-fold
change in fura-2 concentration (up to 400 ,uM) was reported
to have little effect on the peak of the [Ca21], transient. One
reason for these contradictory results could be that cell di-
alysis in the present experiments causes a time-dependent
decrease in the size of the [Ca21], transient, independent of
changes of cellular fura-2 concentration. Because fura-2
loading was not reversed in these experiments, it is not pos-
sible to exclude this possibility. However, consistent with this
idea, the amplitude of the inward current elicited by a de-
polarizing voltage clamp pulse did decrease 40% during the
period of fura-2 loading (data not shown). Thus, we can not
rule out that factors other than fura-2 concentration affect the
size of the [Ca21], transient.
To avoid the problems inherent in the experiment above,
the effects of fura-2 on Ca2' buffering were estimated in
another set of experiments in which the size of the [Ca21]1
transient was compared in furaptra-loaded cells and cells
loaded with low concentrations of fura-2 (10 ,uM in the volt-
age clamp electrode). To minimize the variability inherent in
comparing [Ca2+], transients in different cells, experiments
in fura-2 and furaptra-loaded myocytes were performed on
the same days. Fig. 4 shows the average [Ca2+], transient
determined in four fura-2-loaded (leftpane!) and six furaptra-
loaded myocytes (right pane!). In both sets of experiments,
[Ca2+], transients were elicited by 50-ms depolarizations
from -70 to + 10 mV delivered every 5 s. The average peak
[Ca2+]i and the maximal change in [Ca2+]j during the tran-
sient in the fura-2-loaded myocytes was calibrated to be 438
+ 76 and 387 + 65 nM, respectively. In contrast, the average
peak change in [Ca2+], in the furaptra loaded myocytes was
calibrated to be 821 ± 202 nM. The ratio of peak [Ca2+],
change reported by furaptra and fura-2 was 2.1; however, the
difference was not statistically significant. This result con-
trasts with experiments using 5-fold higher concentrations of
fura-2 where this ratio was 3.9 (Table 1) or 6.4 (above) and
the amplitude of transients measured with furaptra were sig-
nificantly larger than those measured with fura-2. Together
these results suggest that Ca2' buffering explains, at least in
part, the difference in the size of the [Ca21], transients re-
ported by the two indicators.
It is worth noting that the average size of the [Ca21]1 tran-
sients measured with fura-2 in Table 1 and Fig. 4 are very
similar despite the 5-fold differences in fura-2 concentration
in the voltage clamp electrode. Although, the cellular con-
centrations of fura-2 were not quantitated in these two sets
of experiments, it was nonetheless very clear that the intra-
cellular fura-2 concentration was greatly reduced when the
pipette concentration of fura-2 was reduced. This conclusion
is based upon the observation that the level of fura-2 fluo-
rescence was much less in cells loaded with the indicator
from pipettes containing 10 ,uM fura-2 as compared to those
voltage clamped with pipettes containing 50 ,uM fura-2.
Thus, our a priori assumption was that the [Ca21], transient
measured in cells loaded with a lower concentration of fura-2
should be larger. In fact, as the ratio of furaptra transients to
fura-2 transients points out, the relative size of the fura-2
transient is larger. The similarity in the absolute amplitude of
the transients simply reflects the smaller [Ca21], transients
in this series of experiments. This is most clearly seen by
comparing the [Ca2+]i transients measured with furaptra.
The average amplitude of the transients was only half of that
reported in Table 1 despite the fact that both sets of experi-
ments were carried out under identical experimental condi-
tions and with equal pipette indicator concentrations. These
results, however, do point out the variability inherent in
working with acutely dissociated myocytes and demonstrate
320 s 570 s
0.5 sec
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FIGURE 4 Comparison of [Ca21],
transients in cells loaded with low
fura-2 concentrations and furaptra.
[Ca2+J1 transients were elicited by
50-ms depolarizations from -70 to
+ 10 mV. The electrode solution con-
tained 10 ,uM fura-2 (left panel) or
300 ,uM furaptra (right panel). The
[Ca2+1] transients displayed are the
average of [Ca2+], transients ob-
served in four cells loaded with
fura-2 and six cells loaded with fu-
raptra.
the importance of doing experiments on the same set of cells,
as was done here, when trying to draw comparisons between
different experimental maneuvers.
The experiments shown in Figs. 3 and 4 demonstrate
that increasing cellular fura-2 concentrations buffer the
[Ca21], transient. However, optical and Ca2' binding
properties of fura-2 have been shown to change in the cel-
lular environment (Li et al., 1987; Konishi et al., 1988),
and it is possible that these changes are dependent on the
cellular concentration of the indicator.
To ensure that the apparent buffering of [Ca2+]i by fura-2
was not an experimental artifact arising from changes in in-
dicator optical properties, furaptra fluorescence transients
were measured in the presence and absence of the nonfluo-
rescent, high affinity Ca2' buffer, BAPTA. In these experi-
ments, myocytes were voltage-clamped with electrodes con-
taining 300 ,uM furaptra and depolarized at 0.2 Hz from -70
to +10 mV for 100 ms. In three cells, the peak change in
[Ca2+]i during the transient was 854 ± 110 nM. When 100
,uM BAPTAwas also included in the pipette solution for four
cells, the peak change in [Ca2+]i was significantly reduced
to 221 ± 58 nM (p < 0.05). Thus, increasing the buffering
capacity of the pipette solution decreased the amplitude of
the [Ca2+], transient, consistent with the ability of fura-2 to
buffer the [Ca2+], transient.
Kinetics of Ca2+ binding to fura-2
Because fura-2 has high affinity for binding with Ca2+, there
has been concern about the ability of this indicator to ac-
curately follow rapid changes in [Ca2+]. Klein et al. (1988)
and Baylor and Hollingworth (1988) have examined the ki-
netics of Ca2+ binding to fura-2 in skeletal muscle fibers.
Both investigations found that the forward and reverse rate
constants for Ca21 complexation were much slower in myo-
plasm than rate constants determined in free solution (Jack-
son et al., 1987; Kao and Tsien, 1988). The slow reverse rate
constant, in particular, estimated in skeletal muscle raises the
possibility that fura-2 might not follow the most rapid
changes in [Ca2+]i during the cardiac muscle [Ca21], tran-
sient so that the estimate of peak [Ca21], might be erronously
small.
The Ca2' affinity of furaptra is more than 200 times less
than fura-2. If the forward rate constant for Ca21 complex-
ation is diffusion limited (approximately 1 X 108 M-1 S-1 in
myoplasm; Baylor and Hollingworth, 1988), the difference
in their apparent affinities would lie in their reverse rate con-
stants. It is, then, likely that furaptra can accurately report
more rapid changes in [Ca21]. In fact, furaptra's fluorescence
change appeared to track fast [Ca21], transients in frog skel-
etal muscle with little kinetic delay (Konishi et al., 1991).
Thus, by comparing the fluorescence transients recorded
with furaptra and fura-2, it may be possible to determine
whether fura-2 fluorescence signals lag behind the true
changes in [Ca21],.
Fig. 5 A compares the [Ca21], transients measured in
cells loaded with furaptra and a low concentration of
fura-2 (10 ,uM in the pipette). For temporal comparison,
the average [Ca21], transient of four fura-2-loaded cells is
scaled (2.1 times) to the same amplitude as the average
[Ca21], transient of six furaptra-loaded cells. The time-to-
peak [Ca21], of the average fura-2 transient is not signifi-
cantly delayed with respect to the furaptra transient. These
data show that the Ca2' binding kinetics of fura-2 do not
lead to significant alterations in the waveform of the
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FIGURE 5 Comparison of the time course of [Ca21], transients measured
with furaptra (dots) and two fura-2 (solid lines) concentrations. [Ca2+]1
transients were elicited by 50-ms depolarizations from -70 to + 10 mV. Cells
were loaded with furaptra by voltage-clamping with pipettes containing 300
,uM indicator. (A) The average [Ca2+], transient in cells loaded with low
fura-2 concentration (10 ,tM in the pipette) is scaled by a factor of 2.1 to
match the peak of furaptra [Ca21], transient and superimposed on the av-
erage transient in furaptra-loaded cells (same data as Fig. 4). (B) Average
[Ca2+], transients calculated from three cells loaded with fura-2 (50 ,uM in
the pipette) and four cells loaded with furaptra. The average [Ca2"]i transient
of the fura-2-loaded cells is scaled by a factor of 6.4 to match the peak for
the average transient in furaptra-loaded cells.
observed [Ca2+]j. Thus, fura-2 kinetics in the myocyte
appear to be fast enough to measure peak [Ca2+],.
Fig. 5 B shows a similar comparison in cells loaded with
furaptra or a higher concentration of fura-2 (50 ,uM in the
pipette). As in Fig. 5 A, experiments were carried out on the
same day in myocytes loaded with fura-2 and furaptra to
minimize the effects of day-to-day variability. Interestingly,
the time to peak [Ca2+], of the average transient measured
with fura-2 is clearly delayed with respect to the transient
measured with furaptra (47 vs. 29 ms) and the rate of decline
of the transient is slower. A similar slowing of the [Ca2+],
transient was observed in two cells voltage-clamped with
pipettes containing 100 ,tM fura-2. Since fura-2 appears to
significantly buffer Ca2+ during the transient (see above and
Appendix I), this delay could reflect the alteration of cellular
[Ca2+]i-dependent Ca21 -handling processes (for example,
Ca2+ release from the sarcoplasmic reticulum; see Discus-
sion) or errors in calculation of the [Ca2+], transient from
changes in furaptra fluorescence (Konishi and Berlin, 1993;
see Discussion).
Calibration of fura-2
Another possible reason for the discrepancy between the size
of the [Ca21], transients reported by fura-2 and furaptra could
be an artifact arising from the different calibration proce-
dures used to convert fluorescence to [Ca2+]i (Konishi and
Berlin, 1993). In Figs. 2-5, the data have been converted
from fluorescence to [Ca21] using calibration parameters
that were determined on the experimental apparatus using
isotonic salt solutions. Several reports, however, demonstrate
that these parameters are likely to be different for indicators
in salt solutions and in the intracellular melieu (Li et al.,
1987; Konishi et al., 1988; Hove-Madsen and Bers, 1992).
In the present study, the effects of changes in three of these
parameters, Rmin, Rmax and ,B, were examined to determine
their importance in affecting the conversion of fura-2 fluo-
rescence to [Ca2+]i. Experiments were performed so that
Rmin, Rmax, and 3 were determined in fura-2-loaded cells by
a method similar to that of Li et al. (1987). Briefly, at the end
of an experiment, the superfusion solution was changed from
the normal HEPES-buffered Tyrode's solution to a Ca2+-free
Tyrode's solution which contained 2.5 mM K2EGTA, the
Ca2+-ionophore, 4-BrA23187, the K+/H+ antiporter, nigeri-
cin, and the mitochondrial uncoupler, 1799. The purpose of
this solution was to inhibit normal cellular Ca21 metabolism
and decrease [Ca2+], to very low levels. Indicator fluores-
cence was followed until it reached a new steady state, usu-
ally 15 min, and Rmin was determined. The superfusion so-
lution was then changed to a Na+-free (K+ substituted), 2
mM Ca2+-containing solution to estimate Rmax. After several
minutes in this solution, a 1 mM MnCl2-containing Tyrode's
solution was introduced to determine the level ofbackground
fluorescence. In several cells, this solution change protocol
resulted in a marked decrease in cell fura-2 concentration as
judged by a large wavelength-independent decrease in fluo-
rescence intensity. These cells were excluded from analysis
of Rma and (3. In other cells, indicator levels did not appear
to markedly change during the calibration procedure. Some
leakage of the indicator may still have occurred. However,
only 03would tend to be overestimated in this case while Rmin
and Rmax would not be affected.
The values of Rmin, Rmax and , for fura-2 determined
in vitro with salt solutions were, respectively, 0.45 ± 0.03,
14.60 ± 1.6 (n = 3), and 13.1 (determined in a glass cap-
illary), whereas the corresponding values of 0.35 ± 0.03
(n = 11), 6.1 ± 0.4 (n = 5), and 9.6 ± 0.9 (n = 5) were
obtained in fura-2-loaded myocytes. All three parameters
were decreased when determined in myocytes as compared
to salt solutions. Of particular note, is the large decrease in
Rmax which was less than half the value in salt solutions. It
is possible that this low value resulted from dialysis of the
low [Ca2+] pipette solution against the cell interior. This
seems unlikely because, after exposure to "1799," the cells
underwent an irreversible contracture which was accompa-
nied by a very large increase of input resistance into the cell.
This suggested that cell dialysis was minimal. Furthermore,
in one cell where the voltage clamp electrode was removed
prior to the calibration procedure, the value of Rmax was
similar to the other in situ calibration trials. Thus, in myo-
cytes, the Ca2+-dependent optical properties of fura-2 are
Biophysical Journal1638
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different than in salt solutions, consistent with the results of
Li et al. (1987).
Fig. 6 shows the effect of using Rmi, R.ax, and , deter-
mined in the cell on the conversion of fluorescence data to
[Ca2+]1. The myocyte was held at -70 mV and [Ca2+], tran-
sients were elicited with the same voltage clamp protocol
used in Fig. 2. The top panel shows the ratio of fluorescence
intensities and the bottom panel shows superimposed tran-
sients which have been converted to [Ca2+]j. The smaller
transient was calculated with parameters determined in vitro
as in Fig. 1, while the larger transient was calculated with
Rmin, Rmax, and (3 determined in this myocyte. There is little
change in the value of resting [Ca2+]i, because Rmin deter-
mined in this cell was very close to the in vitro value (0.39
vs. 0.41, respectively). On the other hand, the peak [Ca2+]i
was calculated to be 350 nM with the parameters determined
in the myocyte vs. 191 nM with in vitro parameters. This
difference is due to the value of Rmax which was 7.3 in this
cell (versus 13.1 from an in vitro calibration). Thus, using
calibration parameters determined in the cell, the size of the
[Ca21]i transient was calculated to be 83% larger than when
using in vitro parameters.
If these in situ calibration parameters were applied to the
data in Fig. 4 in which low concentrations of fura-2 were
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FIGURE 6 In vitro and in situ calibration of fura-2 fluorescence. The top
panel shows the ratio of fluorescence intensities signal for a fura-2-loaded
myocyte. The cell was depolarized from -70 to + 10 mV for 50 ms. The
bottom panel shows superimposed [Ca2], transients calculated by con-
verting the fluorescence ratio signal to [Ca21], with calibration parameters
determined in salt solutions (in vitro) or in the cell at the end of the ex-
periment (in situ) with the Ca2+ ionophore, 4-Br A23187 (see Methods).
Calibration parameters: KD = 239 nM; in vitro: Rmin = 0.42, Rmax = 13.4,
= 13.1; in situ: Rmin = 0.39, Rmax = 7.2, ,3 = 9.8.
used, resting and peak [Ca2+]i during the transients were 158
+ 24 nM and 953 ± 195 nM (n = 4), respectively. The peak
change in [Ca2+]i, 795 + 175, was not significantly different
than the change of [Ca21], in furaptra-loaded myocytes, 821
± 202 nM (n = 6). Thus, by accounting for the effects of
Ca2' buffering by fura-2 and the changes in optical prop-
erties of the indicator in the cell, the [Ca21], transients re-
ported by fura-2 and furaptra appear to be similar.
The other calibration parameter, KD, was not determined
in the myocyte. Binding to cellular proteins, in particular,
may decrease the Ca2' affinity of these indicators (Konishi
et al., 1988). In preliminary experiments, shifts in KD for
Ca21 were observed for fura-2 and furaptra in the presence
of aldolase and albumin (Mapp and Berlin, unpublished
data). It is not clear, however, that these shifts in KD reflect
the change in KD in the cell (Backx and ter Keurs, 1993)
because the magnitude of the affinity shift may be dependent
on protein concentration and possibly the protein species
(Konishi et al., 1988; Uto et al., 1991). Furthermore, attempts
to measure KD in the cell were not successful.
DISCUSSION
The purpose of this study was to re-examine the utility of
using fura-2 to measure transient changes of [Ca21], in car-
diac myocytes. Fura-2 and indo-1 are widely used to measure
transient changes of [Ca21], in cardiac cells, and a major
advantage of these indicators is thought to be the relative ease
with which [Ca21], can be quantitated. There are, however,
many reports suggesting that the ability to quantitate [Ca2+],
with these indicators may be complicated by a number of
factors including changes in the Ca2+-dependent optical
properties in the cell interior (Li et al., 1987), changes in ion
affinity due to protein binding (Konishi et al., 1988) and
solution viscosity (Roe et al., 1990), and indicator quenching
by heavy metals (Roe et al., 1990). Surprisingly, other po-
tential issues, such as Ca2+ buffering and dye saturation,
which also affect the [Ca2+]i reported by these indicators
have not been investigated in cardiac cells.
One obvious way to check the measurements of Ca2+
made with fura-2 (or indo-1) is to have indicators with dif-
ferent Ca2+ binding properties. An obvious candidate for
such a Ca2+ indicator is the bioluminescent protein, ae-
quorin. The Ca2' binding stoichiometry of aequorin, how-
ever, is quite complex and, furthermore, measuring [Ca21],
in single cells has proved to be technically challenging
(Cobbold and Boume, 1984).
Recently, Konishi et al. (1991) demonstrated that the in-
dicator, furaptra, originally reported as a Mg2+ indicator
(Raju et al., 1989), could also be used to measure transient
changes of [Ca2+], in skeletal muscle fibers. Preliminary ex-
periments (Cleeman and Morad, 1991) showed that furaptra
could also measure [Ca2+]i and our previous investigations
(Konishi and Berlin, 1993) demonstrated the utility of fu-
raptra as a Ca2+ indicator in cardiac myocytes. Furaptra has
specific advantages as an indicator to check fura-2. 1) The
KD for Ca21 of furaptra is at least 100-fold less than that of
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fura-2. The low affinity minimizes the possibility that fu-
raptra will become saturated within the range of physiologi-
cal [Ca2+]i and suggests that the kinetics of Ca2' binding are
likely to be much faster than fura-2. 2) The similarity be-
tween the structures of fura-2 and furaptra make it more
likely that these indicators would interact with intracellular
structures in a similar manner. For example, protein binding
might have qualitatively similar effects on the two indicators.
These considerations suggest that it would be interesting to
compare [Ca21], transients measured with furaptra and
fura-2 to examine several of the potential complicating fac-
tors in the use of fura-2 listed above.
Comparison of [Ca2+], transients measured with
fura-2 and furaptra
Fig. 2 shows a typical [Ca21], transient and Table 1 shows
average data that indicate the amplitude of [Ca21]1 transients
calculated in cells loaded with furaptra was four times larger
than the amplitude of [Ca21], transients calculated from
fura-2 fluorescence transients. The experimental conditions
were identical in all other respects except that cells were
loaded with fura-2 (50 ,uM in the electrode) or furaptra (300
,uM in the electrode). In all cases, changes in fluorescence
were converted to [Ca21], using parameters (KD and EbEf for
furaptra; KD, Rmin, Rmax, and (3 for fura-2) determined with
in vitro calibration solutions. These data could call into ques-
tion the accuracy of the [Ca21]1 transients reported by these
indicators. Reasons for this apparent discrepancy are con-
sidered below.
One explanation could be that one or both of the indicators
have pharmacologic actions in the cell that alter the
excitation-contraction coupling mechanism. In fact, we can-
not rule out this possibility. However, simple evaluations of
the excitation-contraction coupling mechanism can be made
in the presence of these indicators. Konishi and Berlin (1992)
demonstrated that several experimental maneuvers including
exposure to isoproterenol, increasing intracellular Na+, and
increasing voltage clamp pulse duration, all increased the
size of the [Ca2+], transient measured with furaptra. Similar
maneuvers in fura-2-loaded myocytes yielded qualitatively
similar effects on the [Ca2+], transient (Table 1 and Berlin
and Konishi, unpublished observations). Thus, to a first ap-
proximation, excitation-contraction coupling behaves in a
similar fashion whether the cells are loaded with fura-2 or
furaptra.
Konishi and Berlin (1993) also considered the possibility
that furaptra does not accurately report peak changes in
[Ca2+]i during the transient. Changes in [Mg2+]i during the
[Ca21], transient could complicate the calibration of Ca21-
dependent changes in furaptra fluorescence and so lead to an
overestimate of the amplitude of the [Ca2+]1 transient. A
computer simulation that estimates changes in [Mg2+]i dur-
ing the [Ca21], transient, however, suggests this error is
likely to be very small for the determination of peak changes
in [Ca2"]i. Thus, furaptra can be used to estimate the peak
of the [Ca2+]i transient.
It is more likely that the discrepancy lies in the measure-
ment and calibration of [Ca2+]i with fura-2. One obvious
explanation is that fura-2 underestimates [Ca2+]i at the peak
of the transient due to the high degree of Ca2' binding (Mar-
ban et al., 1990). Without knowing the KD of fura-2 in the
cell, this possibility can not be excluded. If the KD in the cell
is the same as in vitro calibrations (239 nM), fura-2 is 65%
bound with Ca2' at the peak of the average [Ca21], transient.
The degree to which fura-2 is likely to underestimate the
amplitude of the [Ca21], transient will depend on the size of
the spatial gradients of [Ca21]1 which may exist during rapid
release of Ca21 from the sarcoplasmic reticulum (Cannell
and Allen, 1984; Wier and Yue, 1986). Our own model (see
Appendix II), however, predicts that, even in the extreme, the
underestimate would be too small to account for the differ-
ences in the amplitude of the [Ca21], transients reported by
fura-2 and furaptra.
We also examined three additional factors which could
lead fura-2 to underestimate the size of the [Ca21], transient.
The results of this study suggest that binding kinetics of Ca21
to the indicators do not explain the discrepancy. On the other
hand, buffering of [Ca2+]i by fura-2 and the determination
of calibration parameters do appear to explain, at least in part,
the differences in the amplitude of the [Ca21], transients re-
ported by these two indicators.
Buffering of [Ca2+J1 by fura-2
Experimental data and computer simulations (see Appendix
I) support the contention that fura-2 significantly buffers
[Ca2+]i during the transient. The intrinsic calcium buffering
capacity of myocytes is likely to be in the hundreds of mi-
cromolar. However, by comparing the presumed affinity of
these intracellular buffers (Fabiato, 1983), it is clear that
fura-2 could be potent buffer within the cell, even if the
affinity is lower in the cell than in in vitro solutions (Konishi
et al., 1988).
Several studies have demonstrated that fura-2 can buffer
[Ca2+]i during stimulated transients. Baylor and Holling-
worth (1988) demonstrated that fura-2 concentrations greater
than 100 ,uM caused briefer antipyrylazo III transients, pre-
sumably due to buffering of [Ca2+]i by fura-2. Timmerman
and Ashley (1986) showed that fura-2 concentrations as low
as 6 ,uM could buffer the [Ca21], transient in barnacle muscle
fibers. The present study also suggests that fura-2 signifi-
cantly buffers [Ca21],. With 50 ,uM fura-2 in the pipette, the
size of the [Ca21], transients were four to six times smaller
than those estimated in furaptra-loaded cells under the same
experimental conditions. Lowering pipette fura-2 concen-
tration to 10 ,uM (and also decreasing cellular indicator con-
centration), decreased the relative difference in the [Ca21],
transients measured with fura-2 and furaptra to two to one.
These results are further supported by experiments in which
the amplitude of [Ca2+], transients measured with furaptra
were decreased 4-fold with 100 ,uM BAPTA added to the
pipette solution. BAPTA is structurally related to fura-2 and
has a similar Ca2' affinity. These experiments demonstrate
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it also has similar effects on the [Ca2+]i transient. Thus, in
the range of concentrations used in these experiments, fura-2
does buffer [Ca21], in myocytes.
Backx and ter Keurs (1993) also found that the size of the
[Ca21], transient and contractile force decreased as fura-2
concentration increased in iontophoretically injected papil-
lary muscles. However, the change in the size of the [Ca21],
transient was much smaller than reported here. The differ-
ence may be due to a smaller change in cellular fura-2
concentration or the fact that measurements were made
over a 3-h period as fura-2 concentration in the muscle
slowly decreased.
Cleeman and Morad (1991) reported that an 8-fold in-
crease in cellular fura-2 concentration (up to 400 ,uM is pre-
sumed by the authors) did not reduce the peak of the stimu-
lated [Ca2+]i. The difference in the present results might be
that Cleeman and Morad (1991) also included cAMP in their
pipette solution. Thus, as fura-2 loaded in the cell, cAMP also
loaded into the cell, so that the level of sarcoplasmic reticu-
lum [Ca2+]i release would be expected to increase and offset
the increased buffering capacity due to fura-2. In contrast, we
generally observed a time-dependent decrease in the size of
the [Ca21], transient during loading. However, time-
dependent changes in excitation-contraction coupling in dia-
lyzed myocytes can not be ruled out unless indicator loading
can be reversed. For this reason, experiments such as that
shown in Fig. 3 are probably unreliable to judge the ability
of fura-2 to buffer [Ca21]i. This was the motivating reason
for conducting the experiments in Fig. 4 at the time when dye
loading was near steady state levels. This insured that dif-
fering degrees of cell dialysis would not complicate the com-
parison of [Ca21], transients in fura-2- and furaptra-loaded
myocytes.
The ability of fura-2 to buffer [Ca2+]i during the transient
demonstrates that this is one factor which explains the
smaller amplitude of [Ca21], transients measured in fura-2
loaded myocytes. The data also point out that Ca2' buffering
may not be the only explanation for these differences.
Kinetics of Ca2+ binding to fura-2
In frog skeletal muscle fibers, fura-2 does not accurately
track fast [Ca21]1 transients (Baylor and Hollingworth, 1988;
Klein et al., 1988). From the fura-2 fluorescence signals in
myoplasm, the apparent dissociation rate constant of fura-2
was calculated to be 12 s-1 at 6-10°C (Klein et al., 1988) and
23 s-1 at 16°C (Baylor and Hollingworth, 1988). These val-
ues are substantially smaller than the dissociation constant
for fura-2 measured using rapid mixing (84 s-1; Jackson
et al., 1987) or temperature-jump apparatus (97 s-1; Kao and
Tsien, 1988) in free solution at 20°C. Baylor and Holling-
worth (1988) suggested that the slowing of fura-2 binding
kinetics in the myoplasm might correlate to the degree of
fura-2 binding to intracellular constituents. Thus, it was
somewhat of a surprise that the fura-2 [Ca21], transient did
not substantially lag behind furaptra [Ca2+]l transient in car-
The extent of fura-2 binding in the myoplasm appears to
be similar in skeletal muscle fibers (Konishi et al., 1988) and
cardiac myocytes (Blatter and Wier, 1990). Thus, our a priori
expectation was that fura-2 Ca2' binding kinetics would also
be similar; however, this does not appear to be the case. A
dissociation rate constant of 23 s-1 or less would show a
significant kinetic lag in the [Ca21], transient signals. In Fig.
5 A, no significant kinetic delay is observed. Even in Fig. 5
B, where the peak of the [Ca21], transient in fura-loaded cells
is delayed with respect to the peak of furaptra [Ca21], tran-
sient, the binding kinetics of fura-2 must be much faster than
those reported in skeletal muscle (see Appendix II).
One explanation for the more rapid kinetics is that fura-2
binds to different proteins in cardiac cells and skeletal muscle
fibers with the consequence that the Ca2' binding properties
are altered differently in these two tissues. Konishi et al.
(1988) and Uto et al. (1991) have demonstrated that protein
binding can alter the KD of fura-2 for Ca2+ (but see Backx
and ter Keurs, 1993). Nonetheless, with the exception of
parvalbumin (Inaguma et al., 1991), the intracellular proteins
in cardiac muscle are more notable for their similarities,
rather than their differences, to proteins in skeletal muscle.
Since the degree of indicator binding is similar in skeletal
(Konishi et al., 1988) and cardiac muscle (Blatter and Wier,
1990), it seems unlikely that differences in indicator protein-
binding underlie the apparently faster kinetics of fura-2 ob-
served in cardiac muscle.
Another possibility is that fura-2 Ca2+ binding kinetics in
skeletal muscle have been underestimated. This explanation
takes into account the more rapid rate of Ca2' release from
sarcoplasmic reticulum in skeletal muscle and the manner in
which fura-2 binding kinetics have been determined (Baylor
and Hollingworth, 1988; Klein et al., 1988). The [Ca2+]i
transient measured with furaptra has a much faster time
course in skeletal muscle (time to peak 5-6 ms with action
potential stimulation at 16°C (Konishi et al., 1991)) than in
cardiac muscle (time to peak 30-40 ms at 23°C; this study).
Thus, fura-2 fluorescence signals may follow the slower rise
of the [Ca2+], transient in cardiac muscle with smaller kinetic
delay than that expected for the faster [Ca2+]1 transient in
skeletal muscle. In addition, the rapid rate of Ca2+ release
from skeletal muscle sarcoplasmic reticulum (SR) would
transiently form a large spatial gradient of [Ca2+]i (Cannell
and Allen, 1984). In the presence of spatial gradients of
[Ca2+], that lead to a high fraction of the indicator being
bound with Ca2 , it is likely that the binding kinetics of
fura-2 would be underestimated, because changes in the in-
dicator signal will not only be limited by binding kinetics but
also by saturation (see Appendix III).
How important is indicator saturation in affecting the cal-
culation of Ca2+ binding kinetics in cardiac and skeletal
muscle fibers? This question cannot be answered in absolute
terms, but it is likely to be more important in skeletal muscle,
where the rate of Ca2' release from SR appears to be more
rapid than in cardiac muscle. Furthermore, the peak [Ca2+]i
during the transient is higher (see Baylor and Hollingworth
diac myocytes at 23°C.
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(1988) and Klein et al. (1988)). Both of these factors tend to
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produce greater fura-2 saturation. Thus, if the kinetic rate
constants for Ca2' binding to fura-2 are underestimated, the
magnitude of the error is likely to be larger in skeletal muscle.
Are the data of the present study entirely consistent with
fura-2 having rapid Ca2' binding kinetics? It was noted in
fura-2 loading experiments, that with increasing fura-2 in the
cell, the [Ca21], transient became smaller, as expected, but
the time-to-peak [Ca21], was delayed with respect to the
furaptra transient and the decaying phase of the transient also
appeared to become slower (i.e., Fig. 5 A vs. Fig. 5 B and
Backx and ter Keurs, 1993). As a fast buffer, fura-2 would
simply be expected to decrease the size of the transient with-
out affecting its waveform, if there are no other changes in
Ca2' release or uptake processes during the transient.Aslow
buffer, on the other hand, would likely slow the time-to-peak
and, possibly, the falling phase of [Ca21], transient with in-
creasing indicator concentration. Thus, although these data
could suggest that fura-2 binding kinetics are slow, other
explanations for the slowing of the [Ca21], transient are pos-
sible. For example, Hollingworth et al. (1992) and Jacque-
mond et al. (1991) noted that increasing intracellular fura-2
concentration increased SR Ca2' release, presumedly by
buffering [Ca2+]i and thereby decreasing Ca2+-dependent
inactivation of SR Ca2' release (Simon et al., 1991). Simi-
larly, in cardiac cells, buffering concentrations of fura-2 in
the cell might decrease any Ca2' dependent inactivation
mechanism for SR Ca2' release (Fabiato, 1985). This could
result in a prolongation of release and, possibly, a delay in
the time-to-peak [Ca2+]j. Another possible explanation is
that increased buffering by fura-2 decreases [Ca21], which
could slow the rate of Ca2' removal from the cytosol. First,
Na/Ca exchange rate has been shown to be allosterically
regulated by [Ca21], (Miura and Kimura, 1989). Although,
this regulation was originally reported to saturate at or below
50 nM [Ca21]i, other reports (Collins et al., 1992) suggest
that concentrations of Ca21 which allosterically regulate
transport rate may be much higher. Thus, higher [Ca21], in
the furaptra transient may activate faster Na/Ca exchange and
increase the decay rate of the transient. Previous data have
shown that larger [Ca21], transients decline at a faster rate,
independent of the Na/Ca exchange mechanism (Berlin et al.,
1990), also consistent with the faster decline of the furaptra
Ca21 transient.
In terms of explaining the difference between the ampli-
tude of the [Ca21], transient reported by fura-2 and furap-
tra, the kinetics of Ca2' binding to fura-2 appear to be
rapid enough that the peak [Ca21], will not be significantly
increased by correcting for the kinetic limitations of the
indicator.
Changes of Ca2 -dependent optical properties of
the Ca2+ indicators
The optical properties of fura-2 and other fluorescent indi-
cators have been shown to be altered by solution viscosity,
pH, ionic strength and presence of proteins (Konishi et al.,
1988; Roe et al., 1990; Uto et al., 1991). The sensitivity of
indicator fluorescence to environmental factors is a major
factor in questioning the accuracy of [Ca2+]i calculated from
indicator fluorescence with the calibration parameters de-
termined in vitro with saline solutions. Li et al. (1987) and
the present results demonstrate that the optical properties of
fura-2 (as judged by the values of Rmin, Rma, and 13) are
different in salt solutions and in the myocyte interior. With
respect to comparing [Ca21], transients measured by fura-2
and furaptra, this change of calibration parameters is par-
ticularly important because only fura-2 calibration requires
Rmin, Rmax and 13. Using parameters determined in the cell,
changes in fura-2 fluorescence convert to [Ca21], transients
which are 50-100% larger than when fluorescence is con-
verted to [Ca21] with calibration parameters determined in
salt solutions. Thus, use of in vitro calibration parameters
leads to an underestimate of the amplitude of the [Ca2+],
transient determined from fura-2 fluorescence.
We did not systematically investigate how theKD for Ca21
of fura-2 and furaptra changes in the cell. However, the Ca2,
affinity of fura-2 is reported to decrease in the presence of
proteins found in the intracellular environment (Konishi
et al., 1988; Uto et al., 1991). Hove-Madsen and Bers (1992)
also found that indo-1 bound to cardiac tissue homogenates
has a lower affinity for Ca2+. Thus, while the affinity of
fura-2 in the myoplasm is unknown, it could be lower than
determined with in vitro salt solutions. This conjecture, how-
ever, is in contrast to the lack of a marked difference in Ca2+
affinity of fura-2 determined in vitro and in iontophoretically
loaded papillary muscles (Backx and ter Keurs, 1993) by a
calibration technique similar to that used to determine in situ
calibration parameters in Fig. 6. The explanation for why
Backx and ter Keurs (1993) observe much smaller changes
in fura-2 optical properties than the present results and those
of Li et al. (1987) and the lack of change in fura-2 Ca2+
affinity is not clear.
Fura-2 is approximately 70% bound to cellular constitu-
ents in skeletal muscle fibers (Konishi et al., 1988) and car-
diac myocytes (Blatter and Wier, 1990). Binding to cellular
constituents is also likely to be largely responsible for any
change in Ca2' affinity of fura-2 in the cell. Similarly, fu-
raptra is 40-50% bound in skeletal muscle (Konishi et al.,
1991), and it seems reasonable to expect that binding of fu-
raptra to cellular constituents would have similar effects on
its Ca2' affinity because the indicators are structurally simi-
lar (Raju et al., 1989). This idea is supported by preliminary
experiments (Mapp and Berlin, unpublished data) which
demonstrated that the Ca2' affinity of furaptra was decreased
in the presence of proteins, similar to the change in Ca2+
affinity of fura-2 (Konishi et al., 1988; Uto et al., 1991).
Thus, the absolute Ca2' affinities of fura-2 and furaptra in
myocytes are unknown. However, if a shift in Ca2" affinity
occurs, it will likely be qualitatively similar for both indi-
cators and will not affect the interpretation of the present
results.
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CONCLUSION
The size of [Ca2+]i transients estimated in fura-2-loaded
myocytes are smaller than those in furaptra-loaded myocytes
under identical experimental conditions. The difference in
the size of the [Ca21], transients reported by these two in-
dicators is due to at least two factors, Ca2+ buffering by
fura-2 and conversion of indicator fluorescence to [Ca2+]
with in vitro calibration parameters. Additional factors can
not be excluded; however, the Ca2' binding kinetics of
fura-2 do not appear to significantly contribute to the smaller
size of the [Ca2+1] transients measured with fura-2. An ad-
ditional point is that Ca2+ buffering by fura-2 may signifi-
cantly change the time course of the [Ca2+], transient even
though it appears to behave as a fast Ca2+ buffer.
The Ca2+ binding kinetics appear to be more rapid than
previously reported in skeletal muscle fibers, but the reason
why the kinetics would be faster in cardiac myocytes is not
clear. These kinetics are rapid enough that fura-2 fluores-
cence might significantly lag only during the most rapid rise
of [Ca2+]i during a stimulated transient.
These results are also generally applicable because Ca21
buffering by Ca2+ indicators and use of in vitro calibration
parameters can lead to underestimates of changes in [Ca21],
in a variety of cell types.
TABLE 2 Intracellular Ca2+ buffers
I I KD kf kr
Species (ttmol/l) (M) (M-1 s-1) (s-')
Cellular Ca2l buffers
Fura-2 84 2.40e-07 2.70e08 65
Troponin-Ca 70 2.00e-06 1.25eO8 250
SR Ext. site 47 1.OOe-06 1.25eO8 125
Sarcolemma 1124 1.OOe-04 1.25eO8 12500
Cellular Ca2+/Mg2+ buffers
Furaptra -Ca 480 4.70e-05 1.25eO8 5875
-Mg 3.60e-03 3.33eO4 120
Troponin-Ca 2 X 70 3.30e-09 l.OOeO8 0.33
-Mg 3.30e-05 3.33eO4 1.11
Myosin -Ca 2 X 70 3.33e-08 1.37eO7 0.46
-Mg 3.64e-04 1.57eO4 0.057
CaMod 1-Ca 6 1.88e-06 1.25eO8 235
-Mg 1.96e-03 3.33eO4 64.7
CaMod 2-Ca 1.84e-06 230
-Mg 2.92e-03 96.4
CaMod 3-Ca 7.49e-06 938
-Mg 1.25e-03 51.3
CaMod 4-Ca 6.14e-05 7675
-Mg 6.14e-03 203
Intrinsic buffer concentrations and the KD values are taken from Fabiato
(1983). Forward rate constants (kf) for Ca2+ (Robertson et al., 1981) and
Mg2+ (Konishi and Berlin, 1993) were used to calculate the reverse rate
constants (kr). The forward rate constant for fura-2 was calculated assuming
kr = 65 s-5 (see Appendix II) and KD = 239 nM. Cellular fura-2 concen-
tration was determined in two cells (see Appendix I) and furaptra concen-
tration was assumed to be concentrated in the cell to the same degree as
fura-2.
APPENDIX
This appendix describes computer simulations to predict the effects of
three potential problems of high affinity Ca2" indicators: 1) Ca2' buffering,
2) kinetic limitations of Ca2' binding, and 3) spatial gradients of [Ca21],
within a sarcomere.
1. Ca2l buffering by fura-2
In spite of the results of the experiments described above, we were con-
cerned by the apparently contradictory results reported by Cleeman and
Morad (1991). Thus, to examine the question of fura-2 buffering of Ca2 ,
we constructed a simple computer simulation to predict how many moles
of Ca21 might be involved in producing the [Ca2+]1 transients reported by
fura-2 and furaptra. The goal of these simulations was to determine if the
amount of the Ca21 involved in the transients was similar despite the dif-
ference in the size of the [Ca2+]1 transient. This would demonstrate that Ca2+
buffering by fura-2 could significantly decrease the amplitude of the [Ca2+1]
transient.
The simulations were very similar to those outlined in Konishi and Berlin
(1993) that examined changes in [Mg2+]i during the [Ca2+], transient. In
brief, the model used for the simulations assumed the cytosolic space ac-
cessible to the indicator and other Ca2+ buffers was a single compartment.
The total Ca21 involved in the [Ca21], transient ([Ca21]tot) was calculated
as the sum of free Ca2+ and the concentration of Ca2'-bound intrinsic
buffers (CaBs) at time, t,
[Ca2+],t (t) = [Ca2+]i(t) + WCaB,(t) (Al)
The intrinsic Ca2+ buffers are listed in Table 2. The cellular concentra-
tions (expressed as gxmol/liter cell H20) are taken from Fabiato (1983).
These concentrations appear to be reasonable based on the report of
Sipido and Wier (1991) who examined intrinsic Ca2' buffering in guinea
pig myocytes.
For these simulations, fura-2 would be a major Ca2+ buffer so the cellular
concentration of fura-2 was examined experimentally by a method similar
to that reported by Klein et al. (1988). Briefly, cells with simple rod-shaped
geometry were chosen for these experiments and width, length, and depth
were measured as described in the Methods section. The cells were voltage-
clamped with electrodes containing 50 ALM fura-2 and fluorescence during
illumination with 360-nm light (i.e., at the isosbestic point) was monitored
until near steady-state levels were attained. Fluorescence was then expressed
on a per volume basis with the assumption that 25% of cell volume was
inaccessible to the indicator. Immediately after the experiment, a glass cap-
illary (10-20 ,um diameter) filled with the same fura-2 containing intra-
cellular solution was illuminated with 360-nm light and the fluorescence
was adjusted for the illuminated volume of the capillary. Intracellular
fura-2 concentration was then calculated by comparing the relative
volume-adjusted fluorescence intensities measured in the cell and in the
capillary. This procedure was successfully completed in two cells and the
intracellular concentrations of fura-2 were calculated to be 82 and 86
,tM. Thus, at steady state loading in both cells, fura-2 was concentrated
in the cytosol relative to the electrode. This result is not surprising in
light of the recent reports showing that fura-2 is highly bound within the
myoplasm of skeletal muscle fibers (Konishi et al., 1988) and cardiac
myocytes (Blatter and Wier, 1990).
For computer simulations, intracellular fura-2 concentration was as-
sumed to be 84 ,uM (see Table 2). Similar experiments were not performed
to determine the cellular concentration of furaptra, because it was assumed
that this indicator would likely be a relatively minor Ca2' buffer within the
cell. This assumption was confirmed by the simulations. Nonetheless, fu-
raptra has also been shown to bind to intracellular constituents in skeletal
muscle fibers, although to a slightly lesser degree than fura-2 (Konishi et al.,
1991). For these simulations, the relative increase in furaptra concentration
in the cell was assumed to be the same as for fura-2. Thus, with a pipette
concentration of 300 p.M in all experiments, the cellular furaptra concen-
tration was assumed to be 480 ,uM.
[Ca2+]I.0 was calculated as a function of time by assuming that [Ca21],
was initially in equilibrium with all cellular buffers. The change in bound
Ca21 to each buffer was calculated using an Euler's numerical integration
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routine (Simon, 1972) to solve the following:
daB=(t)= B.(t) X Ca(t) X kf,x + CaB,(t) x krbXdt
A.
(A2)
where B.(Q) and CaB,(t) are the free and Ca2+-bound forms of a buffer,
respectively. Backward rate constants (k,,) for each intrinsic buffer
were calculated assuming the on rate constant (kfu) was 1.25 eO8 M-1 s-1
(Robertson et al., 1981). The intrinsic cellular Ca2' buffers are listed in
Table 2. Although there are slow Ca2' buffers within the cardiac cell, par-
ticularly the Ca21/Mg2+ sites of troponin C and myosin, our previous simu-
lations of Ca21/Mg2+ competition within the cardiac cell demonstrated that,
during the rapid changes in [Ca21]i, there are only small changes in amount
of Ca2' bound to these slow buffers (Konishi and Berlin, 1993). Thus, for
the present simulations, these slow buffers have been ignored. Changes in
[Mg2J]i are assumed to be negligible (Konishi and Berlin, 1993). The for-
ward rate constant for fura-2 was calculated by assuming the reverse rate
constant was 65s-1 (Table 2; see Appendix II).
Fig. 7 shows the results of the simulations which compare the estimated
amount of Ca21 ([Ca21]to0) involved in the [Ca21], transients measured in
myocytes loaded with fura-2 and furaptra. Fig. 7A shows a typical [Ca21],
transient in a cell voltage-clamped with an electrode containing 50 ,JIM
fura-2 and depolarized from -70 to + 10 mV for 50 ms. Resting [Ca2+], in
this cell was calibrated to be 62 nM, and the peak [Ca2+]i during the tran-
sient was 483 nM. At rest, the total amount of Ca2+ calculated to be in
the cytoplasm was 15 ,umol/liter cell H20. During the transient, the
waveform of the [Ca2+],O closely follows that of the [Ca21], transient.
This reflects the relatively rapid kinetics assigned to fura-2 and the intrin-
sic Ca2' buffers. At the peak of the [Ca2+]i transient, [Ca2+]t,. was cal-
culated to be 73 ,umol/liter cell H20 or a change of 58 ,umol/liter. In
seven cells, the peak change in [Ca2+]0t during the [Ca2+], transient
averaged 58 ± 8 ,umol/liter (Table 1).
For comparison, Fig. 7 B shows the result of a simulation carried out for
a typical [Ca21], transient from a cell loaded with furaptra. The peak change
in [Ca2+]1 was calibrated to be 1.65 ,uM. The predicted [Ca2+]t.t for this
transient was 82 ,M. The average change in [Ca2+]0tO of the furaptra tran-
sients listed in Table 1 was 77 ± 9 ,tM. This value is larger than that
predicted for the fura-2 transients, but only by 33%, despite the 4-fold
difference in the amplitude of the [Ca2+]1 transients.
Why is it that the 4-fold higher [Ca21], observed in furaptra-loaded cells
only translates into a third more [Ca2+],0? The simulations predict that,
unlike fura-2, furaptra only binds a small fraction of [Ca21]tot, in spite of
the higher furaptra concentration in the cells. The great majority of Ca2 ,
in the presence of furaptra, is predicted to be bound to the intrinsic Ca21
buffers, particularly troponin C and the sarcoplasmic reticulum Ca21
ATPase. On the other hand, in fura-2-loaded cells, the Ca2+ indicator is
predicted to be a major buffer, binding similar, if not greater, amounts of
Ca2+ than troponin or the sarcoplasmic reticulum Ca2' ATPase. Thus, these
simulations predict that fura-2 is a potent Ca2+ buffer in the myoplasm,
consistent with the experimental results.
IL. Effect of correcting for Ca2+ binding kinetics
on the calculated [Ca2+], transient
Fig. 5 A demonstrates that the time course of the [Ca2+1] transient measured
with fura-2 does not show a significant temporal lag when compared to the
[Ca2+], transient measured in furaptra-loaded myocytes. This indicates that
Ca2+ binding kinetics do not significantly limit the ability of fura-2 to
measure the peak of the [Ca21], transient.
Fig. 5 B shows that, with higher intracellular fura-2 concentrations, the
peak of the [Ca2+], transient did lag behind that of furaptra-loaded myocytes.
Although this result is interpreted as an effect of increased fura-2 concen-
tration on cellular Ca2+ metabolism (see Discussion), an alternative inter-
pretation (independent of Fig. 5 A) is that the lag of the [Ca21], transient
in fura-2-loaded cells is due to the kinetics of Ca2' binding to the indicator.
To determine what Ca2' binding kinetics would be consistent with this
possible interpretation, we attempted to kinetically correct the [Ca21], tran-
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FIGURE 7 Estimation of the moles of Ca2l involved in [Ca2+]i tran-
sients. The top panel is a [Ca21], transient determined in a cell loaded with
fura-2 (A) and furaptra (B). The bottom panel is an estimation of the total
[Ca2+] participating in the [Ca2+], transient shown in the top panel. Total
[Ca2+] (in ,mol/liter cytoplasmic H20) was calculated with a one-
compartment model (see text for details) which included the Ca2+ buffers
listed in Table 2.
sient measured with fura-2 to that measured with furaptra. This was ac-
complished by a graphical procedure similar to that outlined by Klein et al.
(1988) which assumes that low affinity Ca21 indicators, such as furaptra,
do not have a significant lag in responding to changes in [Ca2+]. The fluo-
rescence signal from a high affinity indicator is then mathematically cor-
rected with arbitrarily chosen Ca2+ binding rate constants to match the time
course of the Ca21 transient measured with the low affinity indicator.
In Figs. 2-7, fura-2 fluorescence has been converted to [Ca21] with the
ratiometric calibration procedure (Grynkiewicz et al., 1985) that assumes the
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indicator is in rapid equilibrium with [Ca2l]. An alternative procedure is to
convert fluorescence ratio to [Ca21] without any assumptions about the
kinetics of Ca2+/fura-2 binding. The equations for this calibration procedure
are derived below.
If equilibrium binding between Ca2' and fura-2 (D) is not assumed,
changes in the amount of Ca2+-bound fura-2 (DCa) follow a one-to-one
binding equation
d[DCa]
dt= [Ca] X [D] Xk. - [DCa] X kff (A3)
where k0n and k0ff are the forward and backward rate constants for Ca2+
binding, respectively. Because the fractional bound fura-2 (f) equals the
concentration of bound fura-2 divided by the total fura concentration
([Dtot]),
df d[DCa] 1
x Mdt dt [DOT (A4)
Therefore changing fura-2 concentration to fractional bound fura-2 and sub-
stituting Eq. A4 into Eq. A3 yields,
2+ df/dt + f X koff (A)[Ca2,]k0X(1 -f) AS
To solve the relationship between fluorescence ratio (R) and f, the equation
for R from Grynkiewicz et al. (1985) is expressed on terms of f,
alF[D] + alB[DCa] alF(l - f) + alBf (A)
a2F[D] + a2B[DCa] -a2F(1 - f) + a22B f
where ailF, alB are the molar fluorescent coefficients of the indicator at
illumination wavelength 1 (340 nm), and a2F, a2B are the coefficients at
illumination wavelength 2 (380 nm) for the free and Ca2+-bound forms of
fura-2, respectively. Solving for f,
(Rmax -R) + (R-Rmn)X13 (A7)
where Rmmn, Rmax, and 1B have there usual meaning (Grynkiewicz et al.,
1985). Substituting Eq. A7 and its derivative into Eq. A5 gives the final
equation,
E dR/dt X X X (Rm - Rmin) 1
[Ca2+] = (Rmax -R) + (RRmin) X13+ koff X 3X (R-R n)kon (Rm. - R) kon(Rm - R) (A8)
The second term on the right-hand side of this equation is the equilibrium
solution for R vs. [Ca2+] given in Grynkiewicz et al. (1985), and the first
term is the kinetic correction term which depends on the rate of change of
fluorescence ratio (dRldt), kon and experimentally determined constants.
Thus, when R is constant, Eq. A8 simplifies to the equilibrium solution.
Formally, Eq. A8 is similar to equations derived by Klein et al. (1988) and
Sipido and Wier (1991).
This calculation does require discrete values for the forward (kon) and
reverse (kff) rate constants for Ca2' binding to the indicator. These rate
constants are chosen to optimize the time course of Ca2+ transient measured
with fura-2 to that measured with furaptra. In these calculations, the fura-2
[Ca2+], transient was kinetically corrected to the furaptra transient shown
in Fig. 5 B.
Fig. 8 shows the fura-2 transient calculated with Eq. A8 and various
reverse rate constants chosen so that the KD (koff/kon) was 239 nM. The
fura-2 [Ca2+], transient in each panel is scaled and superimposed onto the
furaptra [Ca2+], transient. The time course of the raising phase and the peak
of the [Ca2+]1 transient measured with fura-2 were matched to those of the
transient measured with furaptra to determine which of these arbitrarily
chosen rate constants would most accurately reflect the true rate constants.
As discussed above, this analysis assumes that the [Ca2+], transient recorded
with furaptra does not lag behind changes in Ca2 .
kr = 25 s-12 ' A k, = 12s-'
1i oL
200 ms2.
1.
0.L
kr=65 s- kr=150s-1
FIGURE 8 Kinetic correction of fura-2 fluorescence signals. Each panel
shows the superimposed [Ca21], transients which are the average of those
determined in four furaptra (dashed line) and three fura-2-loaded myocytes
(solid line). The fura-2 [Ca21], transients were calculated by converting the
ratio of fluorescence intensity (R) to [Ca21] with Eq. A8 where k0n and k0ff
were arbitrarily chosen so that KD = 239 nM. The reverse rate constant used
in the calculation is shown at the top of each panel. The scale factors are
2.0 (kff = 12 s-1), 3.1 (koff = 25s-1), 6.2 (k0ff = 65 s-1), and 6.4 (kff =
150 s-1). These data are taken from experiments also shown in Fig. 5 B.
Changing the rate constants has a profound effect on the shape of the
[Ca21], transient calculated from the fura-2 fluorescence transient. With
kinetics (k0ff = 12 or 25 s-1) similar to the reverse rate constants reported
by Klein et al. (1988) and Baylor and Hollingworth (1988), a rapid phasic
component of the [Ca21], transient is predicted which would not be apparent
in the raw fura-2 fluorescence signal. With both these rate constants, how-
ever, it is obvious that the predicted rise and fall of [Ca2+], occur more
rapidly than changes in [Ca2+]i reported by furaptra. Thus, it is likely that
these predicted reverse rate constants for fura-2 are slower than fura-2 ki-
netics in the myocyte. Conversely, when much faster rate constants are
chosen to convert fluorescence ratio to [Ca2+], i.e., koff = 150 s-1, the
waveform of the rise in [Ca2+], lags behind that measured with furaptra. This
suggests that these kinetics are too rapid to be consistent with the observed
furaptra fluorescence transient. For the fura-2 [Ca2+]1 transient shown in
Fig. 5 B, k0ff = 65 s-1 gave the best fit of the rising phase and the peak of
the [Ca21], transient determined with furaptra.
By varying k0ff and k0n independently, it was observed that changing kff
alters the waveform of the [Ca21], transient predicted from the fluorescence
transient, whereas changing k0n simply scales the size of the transient with-
out altering its waveform. This is clear when it is considered that k0ff appears
in only one term of Eq. A8, but ko, is in the denominator of all terms in the
equation.
Only the rising phase and the peak of the fura-2 transient could be fit to
the furaptra transient. The inability to fit the entire waveform of the fura-2
transient to the furaptra transient prevented a determination of k0. and,
therefore, KD in myocytes. There are two possible reasons for the inability
to fit the fura-2 Ca2+ transient to the furaptra [Ca2+], transient. First, Konishi
and Berlin (1993) pointed out that the movement artifact of the furaptra
fluorescence signal is as large or larger than the [Ca2+]-dependent signal,
so that only the rising phase and the peak of the transient can be reliably
related to [Ca2+]j. During the declining phase of the transient, which occurs
during maximal cell contraction, there is no reliable manner to assure the
movement artifact is negligible. Second, the inability to fit the fura-2 tran-
sient could be due to fura-2 buffering [Ca2+]i and the resulting alterations
in Ca2+ dependent metabolism in the cell (see Discussion).
This calculation, therefore, suggests that the reverse rate constant for
Ca2+ binding is approximately 65 s-1, a value which is much faster than that
calculated in skeletal muscle fibers (Klein et al., 1988; Baylor and Holling-
worth, 1988).
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Ill. Influence of intrasarcomere Ca2+ gradients on
indicator fluorescence signals
To illustrate the effects ofdye saturation on the apparent kinetics of indicator
binding, we constructed a simple simulation which models the half-
sarcomere as a 10-compartment space where each compartment occupies an
identical volume (Fig. 9 A). Ca2" indicator concentration is equal in all
compartments, and Ca2" buffering by the indicator is negligible. Ca2" is
released into compartment 1, allowed to diffuse between compartments
according to an one-dimensional diffusion equation and is removed from
each compartment by a linear process (i.e., far from saturation). In these
simulations, Ca2" release occurs for 20 ms at a constant rate. At other times,
the release rate is set to zero. During Ca2+ release, a steep Ca2+ concen-
tration gradient develops from compartment 1 to 10 and then dissipates upon
the cessation of release. In this respect, the simulation is qualitatively similar
to the half-sarcomere models published by Cannell and Allen (1984) and
Wier and Yue (1986).
Fig. 9 B illustrates the results of the simulations run where the Ca2+
indicator had 1) a KD of 0.2 ,M (similar to fura-2) and 2) a KD of 20 ,uM
(similar to furaptra). At all times, Ca2+ binding to the indicator was assumed
to be in rapid equilibrium, i.e., binding kinetics do not influence the results
of the simulation. The dotted line shows the [Ca21] transient reported by the
low affmity indicator. This transient peaks at 2 ,uM and begins to decrease
immediately after the cessation of Ca2+ release. By comparison, the [Ca2+]
transient reported by the high affinity indicator shows a slower rate of raise,
a delayed peak and a smaller amplitude (decreased by about 30%). Thus,
even in the absence of kinetic considerations, the high affinity indicator
reports a smaller transient which appears to be slower than the transient
measured with the low affinity indicator. The underlying reason for the
different waveforms of the [Ca2+] transient is that the high affinity indicator
becomes saturated during the rapid release phase in those compartments
with the highest [Ca2+]. Thus, the high affinity indicator does not accurately
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FIGURE 9 Effect of spatial gradients of [Ca2+]i on the [Ca21], transients
measured with a low and high affmity indicator. (A) Model half sarcomere.
The half sarcomere is modeled as a 10-compartment space where each
compartment occupies 0.1 ,um3. Ca2+ is released only into compartment 1
but is removed from all compartments (see text for details). (B) Ca2+ tran-
sients estimated with a low (KD = 20 ,M) and high affinity (KD = 0.2 j,M)
Ca2+ indicator. Superimposed Ca2+ transients are calculated by assuming
rapid equilibrium between the indicator and Ca21 in each compartment for
the high affinity (solid curve) and low affinity indicator (dashed line). Ca2+
release (i.e., input into compartment 1) occurs from 10-30 ms at a constant
rate (1.5 ,uM/ms).
represent spatial mean [Ca2+] under conditions which produce a high degree
of indicator saturation. The lag in the fluorescence signal of the high affinity
indicator is similar, in some respects, to the kinetic lag of fura-2 reported
in skeletal muscle (Baylor and Hollingworth, 1988; Klein et al., 1988).
The graphical method previously used to calculate the kinetic parameters
of fura-2 Ca2+ binding does not account for the effects of Ca21 gradients
within the sarcomere. If these gradients are large (see Cannell and Allen
(1984)), it is expected that these calculated parameters will be underesti-
mates of the true Ca2' binding kinetics of fura-2. The magnitude of this
underestimate is unknown; however, it could explain the apparent difference
between the faster kinetics of fura-2 reported here and those in skeletal
muscle (Baylor and Hollingworth, 1988; Klein et al., 1988).
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